ONE_HEALTHCARE_PARTNERS_L - Accounts


Company Registration No. 09104811 (England and Wales)
ONE HEALTHCARE PARTNERS LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2018
ONE HEALTHCARE PARTNERS LIMITED
COMPANY INFORMATION
Directors
Mr B T K Davis
Mr S A Ramalingam
Mr A D Stevensen
Mr R H Evans
(Appointed 29 June 2017)
Mr P J Weller
(Appointed 29 June 2017)
Company number
09104811
Registered office
c/o Squire Patton Boggs (UK) LLP
Rutland House
148 Edmund Street
Birmingham
B3 2JR
Auditor
MHA Moore and Smalley
Richard House
9 Winckley Square
Preston
PR1 3HP
ONE HEALTHCARE PARTNERS LIMITED
CONTENTS
Page
Strategic report
1 - 3
Directors' report
4
Directors' responsibilities statement
5
Independent auditor's report
6 - 8
Statement of comprehensive income
9
Group balance sheet
10
Company balance sheet
11
Group statement of changes in equity
12
Company statement of changes in equity
13
Group statement of cash flows
14
Notes to the financial statements
15 - 34
ONE HEALTHCARE PARTNERS LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 30 APRIL 2018
- 1 -

The directors present the strategic report for the year ended 30 April 2018.

Fair Review of the Business

The principle activity of the Group and Company is the operation of private hospitals, the provision of private health care facilities and the provision of central services to subsidiary undertakings involved in the operation of private medical and surgical hospitals.

 

On 30th November 2018, One Hatfield Hospital based in Hertfordshire, commenced trading as a sister hospital to One Ashford Hospital. During the year, One Hatfield became the official medical partner for Watford Football Club and was nominated for best new hospital at the Building Better Healthcare Awards.

 

One Ashford Hospital received a Good rating under its CQC report published 5th September 2017. One Ashford launched a service for Children and Young People which has been well received by the public. The hospital received 100% positive feedback from Consultants that would recommend their family and friends to One Healthcare.

 

The NHS continue to face national challenges from increasing demand and limited resources. One Healthcare will continue to work in close partnership with the local CCG’s to provide the most efficient pathway for the patient.

 

The group has received confirmation from the principal funder that support will be received for 12 months from the signature of the audit report, and therefore the group is considered to be a going concern.

ONE HEALTHCARE PARTNERS LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2018
- 2 -
Principal risks and uncertainties

The group’s operations expose it to a variety of business and financial risks and uncertainties. The most fundamental risks faced by the Group are as follows:

 

Market risk

The Group is reliant upon key commercial relationships with Stakeholders, these relationships are subject to continual review based on financial and contractual criteria. The Group has developed a flexible cost approach model that enables it to manage such risk.

 

Medical/regulatory risk

The Group is subject to the risk of litigation as a result of medical malpractice suits. The Group has insurance policies in place to cover such instances and the Directors are of the view that these policies adequately protect the Group from risk.

 

The Group operates in the healthcare sector, one of the closely monitored and regulated areas of business. Our services are subject to external inspection by registration and other authorities, which are followed by publicly available reports. We also conduct our own internal inspections.

 

Cyber security

The Group’s business could be disrupted if its information systems fail, or if its databases are breached, destroyed or damaged. This could cause financial and reputational impacts. The Group’s information technology continuity plans are continuously reviewed, updated and tested to ensure relevance and responsiveness to this risk.

 

Credit risk

Credit risk arises principally from receivables from customers and cash deposits. Exposure to credit risk from trade receivables is considered to be low because of the nature of One’s customers. The credit risk relating to bank deposits is managed by Group treasury by only investing with major financial institutions.

 

Liquidity Risk

The Group ensures that it has sufficient cash on demand to meet operational expenses for a period of 90 days, including the servicing of financial obligations. One Healthcare Partners has a finance agreement in place with Fern Trading Limited comprising of £55m credit facility, of which £4m remains unutilised.

 

Overall risk management

Overall risk is managed with refence to One Healthcare as a group as a whole.

Key performance indicators

The key performance indicators that the directors use to manage the business are:

 

                         2018     2017

 

Revenue (£000)                     10,242     6,494

Operating loss excluding depreciation and

finance charges(£000)                 (4,750)     (5,075)

In-patient and daycase admissions (No.)              2,591         1,999

 

The decrease in operating loss excluding depreciation and finance charges of £325k was mainly due to reduction in losses within One Ashford of £1,934k, offset by start-up losses in Hatfield.

ONE HEALTHCARE PARTNERS LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2018
- 3 -
Development and future outlook

One Hatfield opened in November 2017 with 3 operating theatres and 30 beds. CQC carried out its inspection of One Ashford in June/July 2017 whereby the hospital received the rating of Good across all categories.

 

The Company operates in the UK, a healthcare market dominated by the NHS and government spending. The population is growing and ageing. The cost of healthcare is increasing faster than general inflation, whilst government spending into the NHS’s hinders the ability to provide timely healthcare.

 

The directors believe that the prospects for private healthcare in the UK healthcare market are good. We believe the NHS will continue to have funding issues which, is likely to result in lengthening waiting lists and further rationing of non-essential treatments. The directors therefore believe that, in the medium to long-term, the company should benefit from individuals recognising the increases in NHS waiting lists are likely to elect to be PMI or self-paying patients.

On behalf of the board

Mr P J Weller
Director
31 January 2019
ONE HEALTHCARE PARTNERS LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 30 APRIL 2018
- 4 -

The directors present their annual report and financial statements for the year ended 30 April 2018.

Principal activities

The principal activity of the company and group continued to be the provision of healthcare services.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mr B T K Davis
Mr S A Ramalingam
Mr A D Stevensen
Mr H W Watkins
(Resigned 8 May 2017)
Mr R H Evans
(Appointed 29 June 2017)
Mr P J Weller
(Appointed 29 June 2017)
Results and dividends

The results for the year are set out on page 9.

No ordinary dividends were paid. The directors do not recommend payment of a dividend.

Auditor

The auditor, MHA Moore and Smalley, is deemed to be reappointed under section 487(2) of the Companies Act 2006.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.

Strategic report

The group has chosen in accordance with Companies Act 2006, s. 414C(11) to set out in the group's strategic report information required by Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008, Sch. 7 to be contained in the directors' report. It has done so in respect of principal risks and uncertainties.

On behalf of the board
Mr P J Weller
Director
31 January 2019
ONE HEALTHCARE PARTNERS LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 30 APRIL 2018
- 5 -

The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and company, and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

 

  •     select suitable accounting policies and then apply them consistently;

  •     make judgements and accounting estimates that are reasonable and prudent;

  •     state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;

  •     prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group’s and company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

ONE HEALTHCARE PARTNERS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF ONE HEALTHCARE PARTNERS LIMITED
- 6 -
Opinion

We have audited the financial statements of One Healthcare Partners Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 30 April 2018 which comprise the group statement of comprehensive income, the group balance sheet, the company balance sheet, the group statement of changes in equity, the company statement of changes in equity, the group statement of cash flows and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

  •     give a true and fair view of the state of the group's and the parent company's affairs as at 30 April 2018 and of the group's loss for the year then ended;

  •     have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

  •     have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Material uncertainty related to going concern

In forming our opinion on the financial statements, which is not modified, we have considered the adequacy of the disclosure made in note 1.3 concerning the group’s ability to continue as a going concern. In order to continue operations for the next 12 months the group is dependent upon the shareholders and other funders. This condition indicates the existence of a material uncertainty which may cast significant doubt as to the group’s ability to continue as a going concern. The financial statements do not include the adjustments that would result if the group was unable to continue as a going concern.

Other information

The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

 

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

  • the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

  • the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.

ONE HEALTHCARE PARTNERS LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF ONE HEALTHCARE PARTNERS LIMITED
- 7 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report and the directors' report.

 

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

 

  • adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or

  • the parent company financial statements are not in agreement with the accounting records and returns; or

  • certain disclosures of directors' remuneration specified by law are not made; or

  • we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

 

In preparing the financial statements, the directors are responsible for assessing the group's and the parent company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: http://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

ONE HEALTHCARE PARTNERS LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF ONE HEALTHCARE PARTNERS LIMITED
- 8 -

Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Karen Hain (Senior Statutory Auditor)
for and on behalf of MHA Moore and Smalley
Chartered Accountants
Statutory Auditor
Richard House
9 Winckley Square
Preston
PR1 3HP
31 January 2019
ONE HEALTHCARE PARTNERS LIMITED
GROUP STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 30 APRIL 2018
- 9 -
2018
2017
Notes
£
£
Turnover
3
10,241,832
6,494,138
Cost of sales
(8,246,576)
(6,633,345)
Gross profit/(loss)
1,995,256
(139,207)
Administrative expenses
(8,835,598)
(6,370,817)
Operating loss
4
(6,840,342)
(6,510,024)
Interest receivable and similar income
8
327
17
Interest payable and similar expenses
9
(6,015,785)
(2,949,395)
Loss before taxation
(12,855,800)
(9,459,402)
Tax on loss
10
185,276
-
Loss for the financial year
(12,670,524)
(9,459,402)
Loss for the financial year is attributable to:
- Owners of the parent company
(11,229,819)
(8,008,513)
- Non-controlling interests
(1,440,705)
(1,450,889)
(12,670,524)
(9,459,402)
Total comprehensive income for the year is attributable to:
- Owners of the parent company
(11,229,819)
(8,008,513)
- Non-controlling interests
(1,440,705)
(1,450,889)
(12,670,524)
(9,459,402)

The group statement of comprehensive income has been prepared on the basis that all operations are continuing operations.

ONE HEALTHCARE PARTNERS LIMITED
GROUP BALANCE SHEET
AS AT
30 APRIL 2018
30 April 2018
- 10 -
2018
2017
Notes
£
£
£
£
Fixed assets
Intangible assets
11
39,363
53,256
Tangible assets
12
68,225,503
53,104,327
Investments
13
15
15
68,264,881
53,157,598
Current assets
Stocks
16
793,756
294,124
Debtors
17
2,836,500
2,047,244
Cash at bank and in hand
5,519,206
415,818
9,149,462
2,757,186
Creditors: amounts falling due within one year
18
(6,998,272)
(6,625,537)
Net current assets/(liabilities)
2,151,190
(3,868,351)
Total assets less current liabilities
70,416,071
49,289,247
Creditors: amounts falling due after more than one year
19
(93,504,670)
(60,907,322)
Net liabilities
(23,088,599)
(11,618,075)
Capital and reserves
Called up share capital
23
670
670
Profit and loss reserves
(22,720,242)
(11,490,423)
Equity attributable to owners of the parent company
(22,719,572)
(11,489,753)
Non-controlling interests
(369,027)
(128,322)
(23,088,599)
(11,618,075)
The financial statements were approved by the board of directors and authorised for issue on 31 January 2019 and are signed on its behalf by:
31 January 2019
Mr P J Weller
Director
ONE HEALTHCARE PARTNERS LIMITED
COMPANY BALANCE SHEET
AS AT 30 APRIL 2018
30 April 2018
- 11 -
2018
2017
Notes
£
£
£
£
Fixed assets
Tangible assets
12
2,675
4,316
Investments
13
1,794
1,794
4,469
6,110
Current assets
Debtors falling due after more than one year
17
45,840,584
42,162,907
Debtors falling due within one year
17
24,019
3,223
Cash at bank and in hand
4,686,525
125,103
50,551,128
42,291,233
Creditors: amounts falling due within one year
18
(143,208)
(203,752)
Net current assets
50,407,920
42,087,481
Total assets less current liabilities
50,412,389
42,093,591
Creditors: amounts falling due after more than one year
19
(53,621,014)
(44,042,612)
Net liabilities
(3,208,625)
(1,949,021)
Capital and reserves
Called up share capital
23
670
670
Profit and loss reserves
(3,209,295)
(1,949,691)
Total equity
(3,208,625)
(1,949,021)

As permitted by s408 Companies Act 2006, the company has not presented its own profit and loss account and related notes. The company’s loss for the year was £1,259,604 (2017 - £551,744 loss).

The financial statements were approved by the board of directors and authorised for issue on 31 January 2019 and are signed on its behalf by:
31 January 2019
Mr P J Weller
Director
Company Registration No. 09104811
ONE HEALTHCARE PARTNERS LIMITED
GROUP STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 APRIL 2018
- 12 -
Share capital
Profit and loss reserves
Total controlling interest
Non-controlling interest
Total
£
£
£
£
£
Balance at 1 May 2016
670
(3,481,910)
(3,481,240)
922,567
(2,558,673)
Year ended 30 April 2017:
Loss and total comprehensive income for the year
-
(8,008,513)
(8,008,513)
(1,450,889)
(9,459,402)
Acquisition of non-controlling interests
-
-
-
400,000
400,000
Balance at 30 April 2017
670
(11,490,423)
(11,489,753)
(128,322)
(11,618,075)
Year ended 30 April 2018:
Loss and total comprehensive income for the year
-
(11,229,819)
(11,229,819)
(1,440,705)
(12,670,524)
Acquisition of non-controlling interests
-
-
-
1,200,000
1,200,000
Balance at 30 April 2018
670
(22,720,242)
(22,719,572)
(369,027)
(23,088,599)
ONE HEALTHCARE PARTNERS LIMITED
COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 APRIL 2018
- 13 -
Share capital
Profit and loss reserves
Total
£
£
£
Balance at 1 May 2016
670
(1,397,947)
(1,397,277)
Year ended 30 April 2017:
Loss and total comprehensive income for the year
-
(551,744)
(551,744)
Balance at 30 April 2017
670
(1,949,691)
(1,949,021)
Year ended 30 April 2018:
Loss and total comprehensive income for the year
-
(1,259,604)
(1,259,604)
Balance at 30 April 2018
670
(3,209,295)
(3,208,625)
ONE HEALTHCARE PARTNERS LIMITED
GROUP STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 30 APRIL 2018
- 14 -
2018
2017
Notes
£
£
£
£
Cash flows from operating activities
Cash absorbed by operations
27
(6,691,171)
(3,868,657)
Interest paid
(3,078,265)
(902,823)
Net cash outflow from operating activities
(9,769,436)
(4,771,480)
Investing activities
Purchase of tangible fixed assets
(10,689,646)
(22,059,049)
Purchase of shares in subsidiary from non-controlling interest
1,200,000
400,000
Purchase of fixed asset investments
-
(15)
Interest received
327
17
Net cash used in investing activities
(9,489,319)
(21,659,047)
Financing activities
Proceeds from borrowings
30,607,900
26,251,747
Repayment of borrowings
(6,245,757)
-
Net cash generated from financing activities
24,362,143
26,251,747
Net increase/(decrease) in cash and cash equivalents
5,103,388
(178,780)
Cash and cash equivalents at beginning of year
415,818
594,598
Cash and cash equivalents at end of year
5,519,206
415,818
ONE HEALTHCARE PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2018
- 15 -
1
Accounting policies
Company information

One Healthcare Partners Limited (“the company”) is a private limited company domiciled and incorporated in England and Wales. The registered office is c/o Squire Patton Boggs (UK) LLP, Rutland House, 148 Edmund Street, Birmingham, B3 2JR.

 

The group consists of One Healthcare Partners Limited and all of its subsidiaries.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

The company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements for parent company information presented within these consolidated financial statements:

 

  • Section 7 ‘Statement of Cash Flows’ – Presentation of a statement of cash flow and related notes and disclosures;

  • Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues’ – Carrying amounts, interest income/expense and net gains/losses for each category of financial instrument; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;

  • Section 33 ‘Related Party Disclosures’ – Compensation for key management personnel.

1.2
Basis of consolidation

In the parent company financial statements, the cost of a business combination is the fair value at the acquisition date of the assets given, equity instruments issued and liabilities incurred or assumed, plus costs directly attributable to the business combination. The excess of the cost of a business combination over the fair value of the identifiable assets, liabilities and contingent liabilities acquired is recognised as goodwill. The cost of the combination includes the estimated amount of contingent consideration that is probable and can be measured reliably, and is adjusted for changes in contingent consideration after the acquisition date. Provisional fair values recognised for business combinations in previous periods are adjusted retrospectively for final fair values determined in the 12 months following the acquisition date. Investments in subsidiaries, joint ventures and associates are accounted for at cost less impairment.

ONE HEALTHCARE PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2018
1
Accounting policies
(Continued)
- 16 -

The consolidated financial statements incorporate those of One Healthcare Partners Limited and all of its subsidiaries (ie entities that the group controls through its power to govern the financial and operating policies so as to obtain economic benefits). Subsidiaries acquired during the year are consolidated using the purchase method. Their results are incorporated from the date that control passes.

 

All financial statements are made up to 30 April 2018. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the group.

 

All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.

1.3
Going concern

The group now has two operational hospitals being One Ashford Hospital and One Hatfield Hospital. As at 30 April 2018, in accordance with the business model, the business had not yet generated any profit. The group was also technically insolvent having negative reserves. The group was therefore dependent on the continued support of its shareholders and other funders. The directors believe that the business model demonstrates that the company will be in a position to repay its debts as they fall due.

 

The directors have considered the group's viability for a period extending at least 12 months from the date these financial statements were approved and as a result of that review consider it appropriate to prepare these financial statements on a going concern basis.

1.4
Turnover

Turnover is recognised at the fair value of the consideration received for healthcare services provided in the normal course of business, and is shown net of VAT. Turnover is recognised based on the date the service is provided.

1.5
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the cost or value of the asset can be measured reliably.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Website development & software costs
20% straight line
1.6
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.

ONE HEALTHCARE PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2018
1
Accounting policies
(Continued)
- 17 -

Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:

Land and buildings leasehold
2% straight line
Fixtures, fittings & equipment
10-20% straight line
Computer equipment
33% straight line
Hospital equipment
33% straight line

No depreciation is charged on assets under construction until they are brought into use in the business, at which point the assets are transferred into the relevant category on the fixed asset register and depreciated over their useful economic life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the profit and loss account.

1.7
Fixed asset investments

Equity investments are measured at fair value through profit or loss, except for those equity investments that are not publicly traded and whose fair value cannot otherwise be measured reliably, which are recognised at cost less impairment until a reliable measure of fair value becomes available.

 

In the parent company financial statements, investments in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses.

A subsidiary is an entity controlled by the group. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.8
Impairment of fixed assets

At each reporting period end date, the group reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

 

The carrying amount of the investments accounted for using the equity method is tested for impairment as a single asset. Any goodwill included in the carrying amount of the investment is not tested separately for impairment.

1.9
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition. Cost is calculated using the first in first out method of accounting.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.10
Cash at bank and in hand

Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

ONE HEALTHCARE PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2018
1
Accounting policies
(Continued)
- 18 -
1.11
Financial instruments

The group has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the group's balance sheet when the group becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

All of the group's financial assets are basic financial instruments.

Impairment of financial assets

Financial assets are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the group transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the group after deducting all of its liabilities.

ONE HEALTHCARE PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2018
1
Accounting policies
(Continued)
- 19 -

Basic financial liabilities, including creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

All of the group's financial liabilities are basic financial instruments.

Derecognition of financial liabilities

Financial liabilities are derecognised when the group's contractual obligations expire or are discharged or cancelled.

1.12
Equity instruments

Equity instruments issued by the group are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the group.

1.13
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset if, and only if, there is a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

ONE HEALTHCARE PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2018
1
Accounting policies
(Continued)
- 20 -
1.14
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.15
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.16
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to the profit and loss account so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to income on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease asset are consumed.

2
Judgements and key sources of estimation uncertainty

In the application of the group’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Critical judgements

The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.

Recoverability of debtors

At each balance sheet date, management review the outstanding trade debtor balances for any items that are not expected to be recovered. This is based on any known financial position of customers, historical speed of payment and any communication with them.

ONE HEALTHCARE PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2018
2
Judgements and key sources of estimation uncertainty
(Continued)
- 21 -
Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Bad and doubtful debt provision

As noted in the critical judgements, management undertake a review of the outstanding trade debtor balances at each balance sheet date. Based upon this review, any balances that are considered irrecoverable are provided against.

3
Turnover and other revenue
2018
2017
£
£
Turnover analysed by class of business
Provision of healthcare services
10,241,832
6,494,138
2018
2017
£
£
Other significant revenue
Interest income
327
17
4
Operating loss
2018
2017
£
£
Operating loss for the year is stated after charging:
Depreciation of owned tangible fixed assets
990,728
796,557
Depreciation of tangible fixed assets held under finance leases
1,099,800
638,217
Loss on disposal of tangible fixed assets
616
-
Amortisation of intangible assets
13,893
13,893
Cost of stocks recognised as an expense
2,654,564
2,301,632
Operating lease charges
19,250
28,527
5
Auditor's remuneration
2018
2017
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the group and company
14,430
4,000
Audit of the financial statements of the company's subsidiaries
18,000
13,000
32,430
17,000
ONE HEALTHCARE PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2018
- 22 -
6
Employees

The average monthly number of persons (including directors) employed by the group and company during the year was:

Group
Company
2018
2017
2018
2017
Number
Number
Number
Number
241
115
6
3

Their aggregate remuneration comprised:

Group
Company
2018
2017
2018
2017
£
£
£
£
Wages and salaries
5,555,914
3,467,944
507,014
450,925
Social security costs
486,911
306,080
63,829
51,874
Pension costs
154,528
38,546
19,628
812
6,197,353
3,812,570
590,471
503,611
7
Directors' remuneration
2018
2017
£
£
Remuneration for qualifying services
446,627
280,319
Company pension contributions to defined contribution schemes
16,917
-
463,544
280,319

The number of directors for whom retirement benefits are accruing under defined contribution schemes amounted to 3 (2017 - 0).

Remuneration disclosed above includes the following amounts paid to the highest paid director:
2018
2017
£
£
Remuneration for qualifying services
154,870
156,132
Company pension contributions to defined contribution schemes
5,733
-
ONE HEALTHCARE PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2018
- 23 -
8
Interest receivable and similar income
2018
2017
£
£
Interest income
Interest on bank deposits
-
17
Other interest income
327
-
Total income
327
17
9
Interest payable and similar expenses
2018
2017
£
£
Interest on finance leases and hire purchase contracts
870,395
548,511
Other interest on financial liabilities
5,145,390
2,400,884
Total finance costs
6,015,785
2,949,395
ONE HEALTHCARE PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2018
- 24 -
10
Taxation
2018
2017
£
£
Current tax
Adjustments in respect of prior periods
(185,276)
-

The actual charge for the year can be reconciled to the expected charge based on the profit or loss and the standard rate of tax as follows:

2018
2017
£
£
Loss before taxation
(12,855,800)
(9,459,402)
Expected tax credit based on the standard rate of corporation tax in the UK of 19.00% (2017: 19.92%)
(2,442,602)
(1,884,106)
Tax effect of expenses that are not deductible in determining taxable profit
19,739
23,987
Unutilised tax losses carried forward
1,779,293
2,231,075
Adjustments in respect of prior years
(185,276)
-
Other permanent differences
(169,067)
(370,956)
Corporate interst rate restriction
812,637
-
Taxation credit for the year
(185,276)
-

The group has tax losses of £28,923,930 (2017: £18,874,880) carried forward for future use.

The Chancellor stated his intention to reduce the main rate of corporation tax from 20% to 19% from 1 April 2017 and to 17% from 1 April 2020. This change was substantively enacted on 6 September 2016.

11
Intangible fixed assets
Group
Website development & software costs
£
Cost
At 1 May 2017 and 30 April 2018
67,149
Amortisation and impairment
At 1 May 2017
13,893
Amortisation charged for the year
13,893
At 30 April 2018
27,786
ONE HEALTHCARE PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2018
11
Intangible fixed assets
(Continued)
- 25 -
Carrying amount
At 30 April 2018
39,363
At 30 April 2017
53,256
The company had no intangible fixed assets at 30 April 2018 or 30 April 2017.
ONE HEALTHCARE PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2018
- 26 -
12
Tangible fixed assets
Group
Land and buildings leasehold
Assets under construction
Fixtures, fittings & equipment
Computer equipment
Hospital equipment
Total
£
£
£
£
£
£
Cost
At 1 May 2017
27,066,035
20,999,228
1,143,786
652,193
4,884,226
54,745,468
Additions
1,569,271
7,293,200
1,859,662
471,943
6,017,628
17,211,704
Transfers
28,292,428
(28,292,428)
-
-
-
-
At 30 April 2018
56,927,734
-
3,003,448
1,124,136
10,901,854
71,957,172
Depreciation and impairment
At 1 May 2017
605,459
-
124,246
234,921
676,515
1,641,141
Depreciation charged in the year
759,339
-
200,198
281,277
849,714
2,090,528
At 30 April 2018
1,364,798
-
324,444
516,198
1,526,229
3,731,669
Carrying amount
At 30 April 2018
55,562,936
-
2,679,004
607,938
9,375,625
68,225,503
At 30 April 2017
26,460,576
20,999,228
1,020,258
416,554
4,207,711
53,104,327
ONE HEALTHCARE PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2018
- 27 -
Company
Fixtures, fittings & equipment
£
Cost
At 1 May 2017
6,898
Additions
775
At 30 April 2018
7,673
Depreciation and impairment
At 1 May 2017
2,582
Depreciation charged in the year
2,416
At 30 April 2018
4,998
Carrying amount
At 30 April 2018
2,675
At 30 April 2017
4,316

The carrying value of land and buildings comprises:

Group
Company
2018
2017
2018
2017
£
£
£
£
Long leasehold
55,793,886
26,460,575
-
-

The net carrying value of tangible fixed assets includes the following in respect of assets held under finance leases or hire purchase contracts.

Group
Company
2018
2017
2018
2017
£
£
£
£
Fixtures, fittings & equipment
11,697,900
4,315,904
-
-
Land and buildings
774,808
-
-
-
12,472,708
4,315,904
-
-
Depreciation charge for the year in respect of leased assets
1,099,800
638,217
-
-

During the year £1,030,859 (2017: £1,347,257) of interest costs directly attributable to the financing of freehold property developments were capitalised at the weighted average cost of the related borrowings. The total capitalised interest at 30 April 2018 was £4,636,733 (2017: £3,605,874).

ONE HEALTHCARE PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2018
- 28 -
13
Fixed asset investments
Group
Company
2018
2017
2018
2017
Notes
£
£
£
£
Investments in subsidiaries
14
-
-
1,794
1,794
Unlisted investments
15
15
-
-
15
15
1,794
1,794
Movements in fixed asset investments
Group
Investments other than loans
£
Cost or valuation
At 1 May 2017 and 30 April 2018
15
Carrying amount
At 30 April 2018
15
At 30 April 2017
15
Movements in fixed asset investments
Company
Shares in group undertakings
£
Cost or valuation
At 1 May 2017 and 30 April 2018
1,794
Carrying amount
At 30 April 2018
1,794
At 30 April 2017
1,794
14
Subsidiaries

Details of the company's subsidiaries at 30 April 2018 are as follows:

Name of undertaking
Registered
Nature of business
Class of
% Held
office
shares held
Direct
Indirect
One Ashford Healthcare Limited
England and Wales
Provision of healthcare services
Ordinary
81.27
One Hatfield Hospital Limited
England and Wales
Provision of healthcare services
Ordinary
93.75
ONE HEALTHCARE PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2018
- 29 -
15
Financial instruments
Group
Company
2018
2017
2018
2017
£
£
£
£
Carrying amount of financial assets
Debt instruments measured at amortised cost
1,615,318
1,415,427
n/a
n/a
Equity instruments measured at cost less impairment
15
15
n/a
n/a
Carrying amount of financial liabilities
Measured at amortised cost
100,381,520
67,433,473
n/a
n/a

As permitted by the reduced disclosure framework within FRS 102, the company has taken advantage of the exemption from disclosing the carrying amount of certain classes of financial instruments, denoted by 'n/a' above.

16
Stocks
Group
Company
2018
2017
2018
2017
£
£
£
£
Raw materials and consumables
793,756
294,124
-
-
17
Debtors
Group
Company
2018
2017
2018
2017
Amounts falling due within one year:
£
£
£
£
Trade debtors
1,608,245
1,413,368
-
-
Corporation tax recoverable
185,276
-
-
-
Other debtors
34,585
2,059
21,490
-
Prepayments and accrued income
1,008,394
631,817
2,529
3,223
2,836,500
2,047,244
24,019
3,223
Amounts falling due after more than one year:
Amounts owed by group undertakings
-
-
45,840,584
42,162,907
Total debtors
2,836,500
2,047,244
45,864,603
42,166,130
ONE HEALTHCARE PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2018
- 30 -
18
Creditors: amounts falling due within one year
Group
Company
2018
2017
2018
2017
Notes
£
£
£
£
Obligations under finance leases
21
2,499,455
957,515
-
-
Trade creditors
1,450,205
958,311
48,899
27,721
Other taxation and social security
121,422
99,386
31,704
96,559
Other creditors
1,329,003
1,949,538
4,647
1,567
Accruals and deferred income
1,598,187
2,660,787
57,958
77,905
6,998,272
6,625,537
143,208
203,752
19
Creditors: amounts falling due after more than one year
Group
Company
2018
2017
2018
2017
Notes
£
£
£
£
Obligations under finance leases
21
8,300,296
3,320,178
-
-
Other borrowings
20
85,204,374
57,587,144
53,621,014
44,042,612
93,504,670
60,907,322
53,621,014
44,042,612
Amounts included above which fall due after five years are as follows:
Payable by instalments
27,872,353
10,850,648
-
-
20
Loans and overdrafts
Group
Company
2018
2017
2018
2017
£
£
£
£
Loans from related parties
4,501,007
2,261,887
790,000
790,000
Other loans
80,703,367
55,325,257
52,831,014
43,252,612
85,204,374
57,587,144
53,621,014
44,042,612
Payable after one year
85,204,374
57,587,144
53,621,014
44,042,612
Amounts included above which fall due after five years:
Payable by instalments
27,872,353
10,850,648
-
-
ONE HEALTHCARE PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2018
20
Loans and overdrafts
(Continued)
- 31 -

The long-term loans are secured by fixed charges over the group assets.

21
Finance lease obligations
Group
Company
2018
2017
2018
2017
£
£
£
£
Future minimum lease payments due under finance leases:
Within one year
2,919,281
1,324,642
-
-
In two to five years
9,305,860
3,815,765
-
-
In over five years
183,492
-
-
-
12,408,633
5,140,407
-
-
Less: future finance charges
(1,608,882)
(862,714)
-
-
10,799,751
4,277,693
-
-

Finance lease payments represent rentals payable by the company or group for certain items of fixtures, fittings and equipment. Leases include purchase options at the end of the lease period, and no restrictions are placed on the use of the assets. The average lease term is 5 years. All leases are on a fixed repayment basis and no arrangements have been entered into for contingent rental payments.

22
Retirement benefit schemes
2018
2017
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
154,528
38,546

A defined contribution pension scheme is operated for all qualifying employees. The assets of the scheme are held separately from those of the group in an independently administered fund.

23
Share capital
Group and company
2018
2017
Ordinary share capital
£
£
Issued and fully paid
67,000 Ordinary shares of 1p each
670
670
ONE HEALTHCARE PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2018
- 32 -
24
Operating lease commitments
Lessee

At the reporting end date the group had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

Group
Company
2018
2017
2018
2017
£
£
£
£
Within one year
23,100
15,400
23,100
15,400
23,100
15,400
23,100
15,400
25
Capital commitments

Amounts contracted for but not provided in the financial statements:

Group
Company
2018
2017
2018
2017
£
£
£
£
Acquisition of tangible fixed assets
-
12,073,783
-
-
26
Related party transactions
Remuneration of key management personnel

The remuneration of key management personnel is as follows.

2018
2017
£
£
Aggregate compensation
520,148
315,401
ONE HEALTHCARE PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2018
26
Related party transactions
(Continued)
- 33 -
Transactions with related parties

During the year the group entered into the following transactions with related parties:

Management charges levied
Purchase of goods
2018
2017
2018
2017
£
£
£
£
Group
Other related parties
-
-
10,126,803
10,946,295
Company
Entities over which the company has control, joint control or significant influence
196,667
305,567
-
-
Interest paid
Interest received
2018
2017
2018
2017
£
£
£
£
Group
Key management personnel
15,800
15,800
-
-
Other related parties
219,005
125,888
-
-
Company
Entities over which the entity has control, joint control or significant influence
-
-
4,951,187
3,871,715
Key management personnel
15,800
15,800
-
-

The following amounts were outstanding at the reporting end date:

Amounts owed to related parties
2018
2017
£
£
Group
Key management personnel
848,612
832,812
Other related parties
4,064,175
4,399,937
Company
Key management personnel
848,612
832,812
ONE HEALTHCARE PARTNERS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2018
26
Related party transactions
(Continued)
- 34 -

The following amounts were outstanding at the reporting end date:

Amounts owed by related parties
2018
2017
Balance
Balance
£
£
Company
Entities over which the company has control, joint control or significant influence
45,840,584
42,162,907
27
Cash generated from group operations
2018
2017
£
£
Loss for the year after tax
(12,670,524)
(9,459,402)
Adjustments for:
Taxation credited
(185,276)
-
Finance costs
6,015,785
2,949,395
Investment income
(327)
(17)
Amortisation and impairment of intangible assets
13,893
13,893
Depreciation and impairment of tangible fixed assets
2,090,528
1,434,774
Movements in working capital:
(Increase) in stocks
(499,632)
(73,005)
(Increase) in debtors
(603,980)
(905,203)
(Decrease)/increase in creditors
(851,638)
2,170,908
Cash absorbed by operations
(6,691,171)
(3,868,657)
2018-04-302017-05-01falseCCH SoftwareCCH Accounts Production 2018.300Mr B T K DavisMr S A RamalingamMr A D StevensenMr H W WatkinsMr R H EvansMr P J Weller091048112017-05-012018-04-3009104811bus:Director12017-05-012018-04-3009104811bus:Director22017-05-012018-04-3009104811bus:Director32017-05-012018-04-3009104811bus:Director52017-05-012018-04-3009104811bus:Director62017-05-012018-04-3009104811bus:Director42017-05-012018-04-3009104811bus:RegisteredOffice2017-05-012018-04-30091048112018-04-3009104811bus:Consolidated2017-05-012018-04-3009104811bus:Consolidated2018-04-30091048112017-04-3009104811core:FurnitureFittings2018-04-3009104811core:FurnitureFittings2017-04-3009104811core:Non-currentFinancialInstruments2018-04-3009104811core:Non-currentFinancialInstruments2017-04-3009104811core:CurrentFinancialInstruments2018-04-3009104811core:CurrentFinancialInstruments2017-04-3009104811core:ShareCapital2018-04-3009104811core:ShareCapital2017-04-30091048112016-05-012017-04-3009104811core:IntangibleAssetsOtherThanGoodwill2017-05-012018-04-3009104811core:LandBuildingscore:LongLeaseholdAssets2017-05-012018-04-3009104811core:FurnitureFittings2017-05-012018-04-3009104811core:ComputerEquipment2017-05-012018-04-3009104811core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2017-05-012018-04-3009104811core:ConstructionInProgressAssetsUnderConstruction2017-05-012018-04-3009104811core:FurnitureFittings2017-04-3009104811core:Subsidiary12017-05-012018-04-3009104811core:Subsidiary22017-05-012018-04-3009104811core:Subsidiary112017-05-012018-04-3009104811core:Subsidiary212017-05-012018-04-3009104811core:Subsidiary122017-05-012018-04-3009104811core:Subsidiary232017-05-012018-04-3009104811bus:PrivateLimitedCompanyLtd2017-05-012018-04-3009104811bus:FRS1022017-05-012018-04-3009104811bus:Audited2017-05-012018-04-3009104811bus:ConsolidatedGroupCompanyAccounts2017-05-012018-04-3009104811bus:FullAccounts2017-05-012018-04-30xbrli:purexbrli:sharesiso4217:GBP